Imfinzi (durvalumab) - AstraZeneca
ALG-094103 - Aligos Therap
anti-PD-L1 therapy - The Wistar Institute
INCB86550 - Incyte
https://jitc.bmj.com/content/11/Suppl_1/A1537
 
Heleen Roose1; Kristina Rekstyte-Matiene1; Sarah Stevens2; Kusum Gupta2; Sandra Chang2; Cheng Liu2; Vladimir Serebryany2; Lillian Adame2; Kha Le2; Antitsa Stoycheva2; Lawrence M Blatt2; Leonid Beigelman2; Sushmita Chanda2; David B Smith2; Julian A Symons2; Andreas Jekle2; Tongfei Wu1
 
Sep 27, 2023
 
Prev Next